Henry Schein Inc header image

Henry Schein Inc

HSIC

Equity

ISIN null / Valor 83527

NASDAQ (2026-02-19)
USD 76.80-1.58%

Henry Schein Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Henry Schein Inc., a Fortune 500 company and member of the S&P 500 index, is a prominent provider of health care solutions, catering to over 1 million customers worldwide. Headquartered in Melville, New York, the company operates in 33 countries and territories, employing approximately 26,000 people. Henry Schein offers a comprehensive range of business, clinical, technology, and supply chain solutions designed to enhance the efficiency and effectiveness of office-based dental and medical practitioners, as well as dental laboratories, government and institutional health care clinics, and other alternate care sites. The company's extensive product portfolio includes over 300,000 branded and corporate brand products, distributed through a centralized and automated network. In 2023, Henry Schein reported sales of $12.3 billion, reflecting a consistent growth trajectory since its public listing in 1995. The company is known for its integrated sales and marketing strategy, which is supported by targeted direct marketing efforts.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-1.32%1Y
-7.63%3Y
20.5%5Y

Performance

28.6%1Y
26.1%3Y
25.9%5Y

Volatility

Market cap

9041 M

Market cap (USD)

Daily traded volume (Shares)

1,116,156

Daily traded volume (Shares)

1 day high/low

70.1 / 68.84

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Penumbra Inc
Penumbra Inc Penumbra Inc Valor: 29290920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.19%USD 340.68
ImmunityBio Inc
ImmunityBio Inc ImmunityBio Inc Valor: 110468647
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.82%USD 8.61
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.42%USD 28.54
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.68%USD 11.89
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.49%USD 14.35
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%USD 7.84
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.13%USD 111.74
Intuitive Surgical Inc
Intuitive Surgical Inc Intuitive Surgical Inc Valor: 1631646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%USD 499.53
Sanofi SA
Sanofi SA Sanofi SA Valor: 1447201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.69%USD 47.38
National Vision Holdings Inc
National Vision Holdings Inc National Vision Holdings Inc Valor: 38523646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.52%USD 27.20